Reuters logo
BRIEF-Sangamo Therapeutics posts Q3 loss per share $0.15
November 9, 2017 / 9:08 PM / a month ago

BRIEF-Sangamo Therapeutics posts Q3 loss per share $0.15

Nov 9 (Reuters) - Sangamo Therapeutics Inc

* Sangamo Therapeutics reports third quarter 2017 financial results

* Q3 revenue $11.8 million versus I/B/E/S view $10.4 million

* Q3 loss per share $0.15

* Sees FY 2017 revenue $30 million to $40 million

* Q3 earnings per share view $-0.19 -- Thomson Reuters I/B/E/S

* Sangamo Therapeutics Inc - ‍company expects that revenues will be in range of $30 million to $40 million in 2017​

* FY2017 revenue view $33.2 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below